"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology

Поділитися
Вставка
  • Опубліковано 28 вер 2024
  • Matthew Zirwas, MD, explains why he believes agents like ruxolitinib cream and upadacitinib have become the optimal treatments for atopic dermatitis, hidradenitis suppurativa, and more.

КОМЕНТАРІ • 3

  • @YourzzTrulyy
    @YourzzTrulyy 11 днів тому

    When will opzelura be available for hs treatement?

  • @Valmerix
    @Valmerix 3 місяці тому

    no creams have ever worked on me i wouldn't expect much